• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers.

作者信息

Kung Tzu-Hsiang, Wang Chia-Chi

机构信息

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and School of Medicine, Tzu Chi University, New Taipei City, Taiwan.

出版信息

Aliment Pharmacol Ther. 2019 Jul;50(2):230. doi: 10.1111/apt.15322.

DOI:10.1111/apt.15322
PMID:31246361
Abstract
摘要

相似文献

1
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers.信函：晚期肝细胞癌中程序性细胞死亡蛋白1（PD-1）靶向免疫疗法：来自一项国际多中心真实世界队列的疗效和安全性数据——问题多于答案
Aliment Pharmacol Ther. 2019 Jul;50(2):230. doi: 10.1111/apt.15322.
2
Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply.信函：晚期肝细胞癌中程序性细胞死亡蛋白-1（PD-1）靶向免疫疗法：来自国际多中心真实世界队列的疗效和安全性数据——问题多于答案。作者回复
Aliment Pharmacol Ther. 2019 Jul;50(2):231-232. doi: 10.1111/apt.15334.
3
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌
Aliment Pharmacol Ther. 2019 Aug;50(3):340-341. doi: 10.1111/apt.15336.
4
Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply.信函：程序性细胞死亡蛋白-1靶向免疫疗法治疗晚期肝细胞癌——作者回复
Aliment Pharmacol Ther. 2019 Aug;50(3):341-342. doi: 10.1111/apt.15368.
5
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives.肝细胞癌中的程序性细胞死亡蛋白 1（PD-1）/程序性死亡配体 1（PD-L1）轴：预后和治疗展望。
Clin Transl Oncol. 2019 Jun;21(6):702-712. doi: 10.1007/s12094-018-1975-4. Epub 2018 Nov 1.
6
Recent developments with immunotherapy for hepatocellular carcinoma.肝细胞癌免疫治疗的最新进展。
Expert Opin Biol Ther. 2018 Aug;18(8):905-910. doi: 10.1080/14712598.2018.1499722. Epub 2018 Jul 20.
7
Overshadowed prospect of programmed cell death protein-1 (PD-1) inhibitor as monotherapy for patients with advanced hepatocellular carcinoma.程序性细胞死亡蛋白-1（PD-1）抑制剂单药治疗晚期肝细胞癌患者的前景黯然失色。
Biosci Trends. 2019;13(3):282-283. doi: 10.5582/bst.2019.01161.
8
Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma.钇-90放射性栓塞联合PD-1抑制剂治疗晚期肝细胞癌
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1799-1802. doi: 10.1007/s00270-018-1993-1. Epub 2018 May 29.
9
Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?肿瘤相关调节性T细胞缺失与PD-1/PD-L1阻断联合应用：肝细胞癌一种有前景的免疫疗法？
Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):93-94. doi: 10.1016/j.hbpd.2018.03.001. Epub 2018 Mar 8.
10
PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.PD-1 和 PD-L1 的上调促进了肝癌患者 CD8(+) T 细胞的凋亡和术后复发。
Int J Cancer. 2011 Feb 15;128(4):887-96. doi: 10.1002/ijc.25397.